Parkinson's Disease, the Subthalamic Nucleus, Inhibition, and Impulsivity

ABSTRACT Although Parkinson's disease (PD) is primarily considered a disorder of initiation of actions, patients also have deficits in inhibitory control, both in the motor and cognitive domains. Impulse control disorders, which can develop in association with dopaminergic medication in a small...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders Vol. 30; no. 2; pp. 128 - 140
Main Authors: Jahanshahi, Marjan, Obeso, Ignacio, Baunez, Christelle, Alegre, Manuel, Krack, Paul
Format: Journal Article
Language:English
Published: United States Blackwell Publishing Ltd 01-02-2015
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Although Parkinson's disease (PD) is primarily considered a disorder of initiation of actions, patients also have deficits in inhibitory control, both in the motor and cognitive domains. Impulse control disorders, which can develop in association with dopaminergic medication in a small proportion of patients with PD, are the symptoms most commonly considered as representing inhibitory deficits. However, there is now also a body of evidence suggesting a role for the subthalamic nucleus (STN), which is ordinarily hyperactive in PD, in inhibitory control. Here, we review evidence from animal studies, imaging studies, and investigations recording STN activity intra‐ or perioperatively in patients with PD having surgery for DBS of the STN (STN‐DBS). We also highlight relevant hypotheses about the role of the STN and consider evidence from studies that have examined the effect of STN‐DBS in patients with PD on performance of experimental tasks requiring inhibition of prepotent or habitual responses or decision making under conflict, as well as the psychiatric side effects of STN‐DBS. Though the results are not always consistent, nevertheless, this body of evidence supports the role of the STN in inhibitory and executive control. © 2014 International Parkinson and Movement Disorder Society
Bibliography:ark:/67375/WNG-PBZJ8L87-S
istex:CA72FFF2CB9B90A710D099799FF33544D045D169
ArticleID:MDS26049
Correction added on 9 January 2015, after first online publication: author affiliation #2 updated.
Full financial disclosures and author roles may be found in the online version of this article.
Nothing to report.
Relevant conflicts of interest/financial disclosures
Funding agencies
This work was supported by a grant from Departamento de Salud, Gobierno de Navarra (14/2009).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.26049